Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Bit Pulls Back Toward Key Support 20260403 1 Is New York Nyt Stock Good For Beginners Price At 85.69 Up 0.35 20260402 Koho Financial Gains Interac Access Intensifying Competition in Canadian Banking Sector Savers SVV Q1 2026 Results Fall Short EPS 002 Revenue NA AIDriven Layoffs May Not Deliver Expected Business Gains Analysis Suggests Starlinks Rapid Growth Propels SpaceX into Internet and National Security Arena Amid Rising Competition Inogen INGN Stock Slides 603 Support at 607 20260515 Microsoft Feared OverReliance on OpenAI Trial Testimony Reveals GigCapital7 GIGGW Slides 268 as Selling Pressure Mounts 20260514 New York Fed Study Reveals Surging Gas Prices Hit LowerIncome Households Hardest SIMA Urges Tamil Nadu CM to Address Critical Power Issues Affecting Textile Mills IIITBangalore Opens Admissions for BTech and Integrated MTech Programmes for 202627 Boosting Indias Technical Talent Pipeline HSBC Holdings Named Among Top Undervalued Dividend Stocks Amid Analyst Price Target Upgrades OpenAI May Confidentially File for IPO as Soon as May 22 Potentially Valued at 1 Trillion Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Shifting Demand Trends SpaceX Postpones Starship Launch as Potential Mega Share Sale Looms Jobless Claims Hold Near Historic Lows Signaling Ongoing Labor Market Resilience AIRelated Layoffs and Stock Performance Not Always a Positive Signal Americans Face Higher Prices Over Memorial Day Weekend as Inflation Accelerates in April LNT Q1 2026 Earnings EPS Beats Estimates by 71 Stock Rises Modestly BLNK Q1 2026 Earnings Narrowing Loss Beats Expectations Stock Rises Danaos Corporation Q1 2026 Earnings Slight EPS Miss Despite Solid Operations RTX Q1 2026 Earnings EPS Surges Past Estimates with 161 Surprise BNED Q4 2025 Earnings NarrowerThanExpected Loss Drives Stock Rally Allarity Therapeutics ALLR Surges 66 as Volume Picks Up Testing Key Resistance PRH Struggles Near 23 as FixedIncome Headwinds Persist JBK Holds Steady at 2622 as Support and Resistance Levels Come into Focus GSK GSK Holds Steady With Modest Gains as Pharma Sector Navigates Uncertainty